Feasibility and user experience of digital patient monitoring for real-world patients with lung or breast cancer

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Arriola Aperribay, Edurne
• dc.contributor.author Jaal, Jana
• dc.contributor.author Edvardsen, Anne
• dc.contributor.author Silvoniemi, Maria
• dc.contributor.author Araújo, António
• dc.contributor.author Vikström, Anders
• dc.contributor.author Zairi, Eleni
• dc.contributor.author Rodriguez Mues, Mari Carmen
• dc.contributor.author Roccato, Marco
• dc.contributor.author Schneider, Sophie
• dc.contributor.author Ammann, Johannes
• dc.date.accessioned 2025-07-21T06:00:23Z
• dc.date.available 2025-07-21T06:00:23Z
• dc.date.issued 2024
• dc.description.abstract Background: Digital patient monitoring (DPM) tools can facilitate early symptom management for patients with cancer through systematic symptom reporting; however, low adherence can be a challenge. We assessed patient/healthcare professional (HCP) use of DPM in routine clinical practice. Materials and methods: Patients with locally advanced/metastatic lung cancer or HER2-positive breast cancer received locally approved/reimbursed drugs alongside DPM, with elements tailored by F. Hoffmann-La Roche Ltd, on the Kaiku Health DPM platform. Patient access to the DPM tool was through their own devices (eg, laptops, PCs, smartphones, or tablets), via either a browser or an app on Apple iOS or Android devices. Coprimary endpoints were patient DPM tool adoption (positive threshold: 60%) and week 1-6 adherence to weekly symptom reporting (positive threshold: 70%). Secondary endpoints included experience and clinical impact. Results: At data cutoff (June 9, 2022), adoption was 85% and adherence was 76%. Customer satisfaction and effort scores for patients were 76% and 82%, respectively, and 83% and 79% for HCPs. Patients spent approximately 10 minutes using the DPM tool and completed approximately 1.0 symptom questionnaires per week (completion time 1-4 minutes). HCPs spent approximately 1-3 minutes a week using the tool per patient. Median time to HCP review for alerted versus non-alerted symptom questionnaires was 19.6 versus 21.5 hours. Most patients and HCPs felt that the DPM tool covered/mostly covered symptoms experienced (71% and 75%), was educational (65% and 92%), and improved patient-HCP conversations (70% and 83%) and cancer care (51% and 71%). Conclusion: The DPM tool demonstrated positive adoption, adherence, and user experience for patients with lung/breast cancer, suggesting that DPM tools may benefit clinical cancer care.
• dc.format.mimetype application/pdf
• dc.identifier.citation Arriola E, Jaal J, Edvardsen A, Silvoniemi M, Araújo A, Vikström A, et al. Feasibility and user experience of digital patient monitoring for real-world patients with lung or breast cancer. Oncologist. 2024 Apr 4;29(4):e561-9. DOI: 10.1093/oncolo/oyad289
• dc.identifier.doi http://dx.doi.org/10.1093/oncolo/oyad289
• dc.identifier.issn 1083-7159
• dc.identifier.uri http://hdl.handle.net/10230/70954
• dc.language.iso eng
• dc.publisher Oxford University Press
• dc.relation.ispartof Oncologist. 2024 Apr 4;29(4):e561-9
• dc.rights © The Author(s) 2023. Published by Oxford University Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.rights.uri http://creativecommons.org/licenses/by/4.0/
• dc.subject.keyword Breast cancer
• dc.subject.keyword Digital patient monitoring
• dc.subject.keyword eHealth
• dc.subject.keyword Lung cancer
• dc.subject.keyword Patient-reported outcomes
• dc.subject.keyword Symptom monitoring
• dc.title Feasibility and user experience of digital patient monitoring for real-world patients with lung or breast cancer
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/publishedVersion